We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
(-14%)
Cap. Flow
-$2.77B
Cap. Flow
% of AUM
-10.63%
Top 10 Holdings %
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$49.4M |
| 2 |
Nucor
NUE
|
+$35.6M |
| 3 |
Essex Property Trust
ESS
|
+$27.5M |
| 4 |
Archer Daniels Midland
ADM
|
+$27.3M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$366M |
| 2 |
Microsoft
MSFT
|
+$279M |
| 3 |
Amazon
AMZN
|
+$213M |
| 4 |
Tesla
TSLA
|
+$109M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.74% |
| 2 | Consumer Staples | 11.79% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Industrials | 10.74% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
676
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.38M | 0.01% |
6,150
+871
| +16% | +$176K |
|
677
News Corp Class B
NWS
$16.4B
| $1.38M | 0.01% |
89,487
+31,040
| +53% | +$529K |
|
678
Alaska Air
ALK
$5.15B
| $1.38M | 0.01% |
35,225
-9,597
| -21% | -$421K |
|
|
Y
679
DELISTED
Alleghany Corp
Y
| $1.38M | 0.01% |
1,639
-53
| -3% | -$44.5K |
|
680
Gaming and Leisure Properties
GLPI
$12.8B
| $1.37M | 0.01% |
31,015
+887
| +3% | +$43.8K |
|
681
Charles River Laboratories
CRL
$10.9B
| $1.36M | 0.01% |
6,906
-811
| -11% | -$175K |
|
682
Domino's
DPZ
$11B
| $1.36M | 0.01% |
4,375
-600
| -12% | -$228K |
|
683
F5
FFIV
$22.1B
| $1.36M | 0.01% |
9,366
-1,426
| -13% | -$226K |
|
684
Apollo Global Management
APO
$70.7B
| $1.35M | 0.01% |
29,141
+2,708
| +10% | +$149K |
|
685
Equity Lifestyle Properties
ELS
$12.8B
| $1.33M | 0.01% |
21,239
-923
| -4% | -$66.3K |
|
|
JNPR
686
DELISTED
Juniper Networks
JNPR
| $1.32M | 0.01% |
50,618
-7,045
| -12% | -$199K |
|
687
Tapestry
TPR
$28.8B
| $1.31M | 0.01% |
46,072
-7,954
| -15% | -$266K |
|
688
Annaly Capital Management
NLY
$16.9B
| $1.3M | 0.01% |
75,902
+25,906
| +52% | +$653K |
|
689
Fox Class A
FOXA
$23.2B
| $1.3M | 0.01% |
42,341
-5,567
| -12% | -$188K |
|
690
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.29M | 0.01% |
9,696
+396
| +4% | +$60.2K |
|
691
CarMax
KMX
$8.27B
| $1.29M | 0.01% |
19,525
-2,622
| -12% | -$240K |
|
692
Jones Lang LaSalle
JLL
$15.1B
| $1.27M | ﹤0.01% |
8,437
-507
| -6% | -$88.3K |
|
693
Lamar Advertising Co
LAMR
$16.2B
| $1.27M | ﹤0.01% |
15,340
-598
| -4% | -$57K |
|
694
First Financial Bankshares
FFIN
$4.97B
| $1.26M | ﹤0.01% |
30,132
-625
| -2% | -$26.9K |
|
|
MPT
695
Medical Properties Trust
MPT
$2.89B
| $1.25M | ﹤0.01% |
105,471
-4,381
| -4% | -$66.4K |
|
696
Bath & Body Works
BBWI
$4.01B
| $1.24M | ﹤0.01% |
38,169
-2,860
| -7% | -$101K |
|
697
Organon & Co
OGN
$3.55B
| $1.23M | ﹤0.01% |
52,686
-3,085
| -6% | -$93.1K |
|
698
Steel Dynamics
STLD
$35.6B
| $1.23M | ﹤0.01% |
17,318
-1,346
| -7% | -$102K |
|
|
NLSN
699
DELISTED
Nielsen Holdings plc
NLSN
| $1.23M | ﹤0.01% |
44,265
-5,530
| -11% | -$144K |
|
700
Henry Schein
HSIC
$9.74B
| $1.22M | ﹤0.01% |
18,536
-2,379
| -11% | -$177K |
|
Similar funds
ProShare Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.
- ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
- ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
- ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
- ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
- ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
- ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
- ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.
Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.